Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (Feb 14, 2013)
-
-
-
Mylan: Profit From The Generics Boom With This PharmaCris Frangold • Thu, Nov 8, 2012 -
-
Analyst Scott Power Finds The Upside In Biotech Down UnderLife Sciences Report • Thu, Nov 8, 2012 -
-
Business Wire (Oct 10, 2012)
-
Business Wire (Oct 8, 2012)
-
-
-
-
-
-
-
India Markets Friday Wrap-Up: Persistent Selling Mars Indian IndicesEquitymaster • Fri, Jul 20, 2012
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
Dr. Reddy's And Pfizer Finally Settle Lipitor DisputeZacks Investment Research • Thu, Sep 1, 2011 -
-
-
-
-
-
-
-
Dr. Reddy's Posts Big Earnings Beat on Nausea Treatment SalesSA Editor Eli Hoffmann • Fri, May 18, 2007 -
Dr. Reddy's Launches Generic ZofranAaron F. Barkoff • Wed, Jan 24, 2007 -
Indian Market Report: Dr. Reddy's Moving Up QuietlyDinesh Pandya • Mon, Dec 25, 2006
-
Reddy's is Ready for Aggressive GrowthHari Vepadharmalingam • Tue, Sep 5, 2006 -
Indian Pharma Companies: No Respite Yet (RDY, RBXLF)Wisdomsmith • Wed, Jan 25, 2006
-
-
-
-
Mylan: Profit From The Generics Boom With This PharmaCris Frangold • Thu, Nov 8, 2012
-
-
Analyst Scott Power Finds The Upside In Biotech Down UnderLife Sciences Report • Thu, Nov 8, 2012
-
-
-
-
-
-
-
India Markets Friday Wrap-Up: Persistent Selling Mars Indian IndicesEquitymaster • Fri, Jul 20, 2012
-
India Markets Wednesday Wrap-Up: Late Buying Fuels Indian IndicesEquitymaster • Wed, Jul 18, 2012
-
India Markets Monday Wrap-Up: Global Signals Lead To Sell-OffEquitymaster • Mon, Jul 9, 2012
-
-
High Flying Indian ADRs: Play A Turnaround In IndiaQineqt • Mon, Jul 2, 2012 -
India Markets Monday Wrap-Up: Volatility Plagues Indian IndicesEquitymaster • Mon, Jul 2, 2012
-
India Markets Monday Wrap-Up: Persistent Selling Mars IndicesEquitymaster • Mon, Jun 18, 2012
-
Dr. Reddy's And Merck Serono Partner On BiosimilarsThe Burrill Report • Sun, Jun 10, 2012
-
at CNBC.com (May 14, 2013)
-
Business Wire (Feb 14, 2013)
-
Business Wire (Oct 10, 2012)
-
at CNBC.com (Oct 8, 2012)
-
Business Wire (Oct 8, 2012)
-
at MarketWatch.com (May 18, 2012)
-
Business Wire (Apr 19, 2012)
-
Business Wire (Jan 16, 2012)
-
at MarketWatch.com (Jul 15, 2011)
-
at MarketWatch.com (Mar 10, 2011)
-
at CNBC.com (Feb 17, 2011)
-
at CNBC.com (Feb 1, 2011)
-
at MarketWatch.com (Jan 19, 2011)
-
at CNBC.com (Jan 11, 2011)
-
at MarketWatch.com (Dec 22, 2010)
-
at MarketWatch.com (Nov 18, 2010)
-
at CNBC.com (Nov 8, 2010)
-
at MarketWatch.com (Jun 15, 2010)
RDY vs. ETF Alternatives
Company Description
Dr. Reddy’s Laboratories Limited (“DRL” or the “parent company”), together with its subsidiaries (collectively, the “Company”), is a leading India-based pharmaceutical company headquartered in Hyderabad, Andhra Pradesh, India. The Company’s principal areas of operation are in pharmaceutical... More
